\-\ Texto\\:\\ \ \(0\)\
\-\ diminished\\ dorsalis\\ pedis\\ and\\ posterior\\ tibial\\ pulses\\ of\\ at\\ left\\ ankle\\.\ \(0\)\
\-\ bilateral\\ vascular\\ by\\-pass\\ grafts\\.\ \(0\)\
\-\ image\\ 1\\ demonstrates\\ occlusion\\ of\\ the\\ majority\\ of\\ the\\ left\\ popliteal\\ artery\\ with\\ medial\\ deviation\\ of\\ the\\ most\\ proximal\\ portion\\ which\\ does\\ contain\\ contrast\\.\ \(0\)\
\-\ image\\ 2\\ demonstrates\\ a\\ patent\\ but\\ also\\ medially\\ deviated\\ right\\ popliteal\\ artery\\ \\(passive\\ plantar\\ flexion\\)\ \(0\)\
\-\ image\\ 3\\ demonstrates\\,\\ with\\ the\\ patient\\ now\\ in\\ active\\ plantar\\ flexion\\,\\ extrinsic\\ compression\\ and\\ continued\\ medial\\ deviation\\ of\\ right\\ popliteal\\ artery\ \(0\)\
\-\ popliteal\\ artery\\ entrapment\\ syndrome\ \(4\)\
\-\ atherosclerotic\\ peripheral\\ vascular\\ disease\ \(2\)\
\-\ popliteal\\ artery\\ entrapment\\ syndrome\ \(4\)\
\-\ thrombosis\\ of\\ a\\ popliteal\\ artery\\ aneurysm\ \(1\)\
\-\ thrombosis\\ of\\ the\\ left\\ popliteal\\ artery\\ due\\ to\\ an\\ intrinsic\\ or\\ aquired\\ abnormality\\ of\\ coagulation\\.\ \(0\)\
\-\ cardiac\\ thromboembolic\\ phenomenon\\.\ \(0\)\
\-\ extrinsic\\ compression\\ by\\ a\\ soft\\ tissue\\ mass\ \(1\)\
\-\ gradually\\ increasing\\ claudication\\ symptoms\\ in\\ left\\ leg\\ with\\ running\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ popliteal\\:\\ 0\\.2645658821144583\ \(0\)\
\-\ artery\\:\\ 0\\.1300124813485941\ \(0\)\
\-\ extrinsic\\:\\ 0\\.07679080821134429\ \(0\)\
\-\ entrapment\\:\\ 0\\.07597956950835436\ \(0\)\
\-\ plantar\\:\\ 0\\.07129478527360834\ \(0\)\
\-\ deviation\\:\\ 0\\.06967105337418902\ \(0\)\
\-\ by\\-pass\\:\\ 0\\.06434684980997443\ \(0\)\
\-\ aquired\\:\\ 0\\.05928738133873396\ \(0\)\
\-\ image\\:\\ 0\\.058449397802137246\ \(0\)\
\-\ flexion\\:\\ 0\\.05741191972817704\ \(0\)\
\-\ thrombosis\\:\\ 0\\.05354779484894956\ \(0\)\
\-\ pedis\\:\\ 0\\.05014312609424222\ \(0\)\
\-\ claudication\\:\\ 0\\.04916844439625301\ \(0\)\
\-\ dorsalis\\:\\ 0\\.048308714208980134\ \(0\)\
\-\ grafts\\:\\ 0\\.04684396460706662\ \(0\)\
\-\ compression\\:\\ 0\\.04669704125985294\ \(0\)\
\-\ intrinsic\\:\\ 0\\.04508365762300175\ \(0\)\
\-\ thromboembolic\\:\\ 0\\.04508365762300175\ \(0\)\
\-\ deviated\\:\\ 0\\.04458006002090721\ \(0\)\
\-\ coagulation\\:\\ 0\\.04410897592501253\ \(0\)\
\-\ vascular\\:\\ 0\\.04090223748793718\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04087491682452232\ \(0\)\
\-\ phenomenon\\:\\ 0\\.04085140583283429\ \(0\)\
\-\ medial\\:\\ 0\\.039902182680146746\ \(0\)\
\-\ passive\\:\\ 0\\.03742072240768293\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.03742072240768293\ \(0\)\
\-\ gradually\\:\\ 0\\.036243582644207586\ \(0\)\
\-\ syndrome\\:\\ 0\\.035677468273498415\ \(0\)\
\-\ medially\\:\\ 0\\.03550565478383263\ \(0\)\
\-\ running\\:\\ 0\\.035096242618496545\ \(0\)\
\-\ contain\\:\\ 0\\.03446112307842626\ \(0\)\
\-\ diminished\\:\\ 0\\.03410499049324792\ \(0\)\
\-\ pulses\\:\\ 0\\.03227057860798583\ \(0\)\
\-\ occlusion\\:\\ 0\\.03110687249902159\ \(0\)\
\-\ patent\\:\\ 0\\.03073246889035333\ \(0\)\
\-\ majority\\:\\ 0\\.030659838738140426\ \(0\)\
\-\ ankle\\:\\ 0\\.029712308727031008\ \(0\)\
\-\ tibial\\:\\ 0\\.028817401266503034\ \(0\)\
\-\ left\\:\\ 0\\.027915482314537655\ \(0\)\
\-\ continued\\:\\ 0\\.026859269977490774\ \(0\)\
\-\ increasing\\:\\ 0\\.025564324415508835\ \(0\)\
\-\ aneurysm\\:\\ 0\\.02465284025579053\ \(0\)\
\-\ leg\\:\\ 0\\.024526987654078805\ \(0\)\
\-\ active\\:\\ 0\\.023814298095218105\ \(0\)\
\-\ cardiac\\:\\ 0\\.023757932795262556\ \(0\)\
\-\ abnormality\\:\\ 0\\.023011371852777754\ \(0\)\
\-\ portion\\:\\ 0\\.02259274925079625\ \(0\)\
\-\ peripheral\\:\\ 0\\.022568856365066548\ \(0\)\
\-\ now\\:\\ 0\\.02132201160366166\ \(0\)\
\-\ does\\:\\ 0\\.02128190562324092\ \(0\)\
\-\ proximal\\:\\ 0\\.01872659256720449\ \(0\)\
\-\ due\\:\\ 0\\.01664435878067766\ \(0\)\
\-\ symptoms\\:\\ 0\\.01554494508684773\ \(0\)\
\-\ soft\\:\\ 0\\.015189246452507663\ \(0\)\
\-\ bilateral\\:\\ 0\\.015137355688426599\ \(0\)\
\-\ 1\\:\\ 0\\.014841798306275232\ \(0\)\
\-\ tissue\\:\\ 0\\.014784096266077325\ \(0\)\
\-\ 3\\:\\ 0\\.01460566077887985\ \(0\)\
\-\ most\\:\\ 0\\.014400256508964059\ \(0\)\
\-\ posterior\\:\\ 0\\.014376923713156558\ \(0\)\
\-\ contrast\\:\\ 0\\.013961866327065002\ \(0\)\
\-\ 2\\:\\ 0\\.013431419682558732\ \(0\)\
\-\ but\\:\\ 0\\.013302943803164508\ \(0\)\
\-\ right\\:\\ 0\\.013162506702341849\ \(0\)\
\-\ also\\:\\ 0\\.012296493384453658\ \(0\)\
\-\ which\\:\\ 0\\.01164339114775583\ \(0\)\
\-\ by\\:\\ 0\\.010385919001787407\ \(0\)\
\-\ disease\\:\\ 0\\.010195164534421198\ \(0\)\
\-\ a\\:\\ 0\\.008684667193108057\ \(0\)\
\-\ mass\\:\\ 0\\.008674897860931128\ \(0\)\
\-\ an\\:\\ 0\\.008625290980180509\ \(0\)\
\-\ at\\:\\ 0\\.008450825933077612\ \(0\)\
\-\ or\\:\\ 0\\.007310385028932172\ \(0\)\
\-\ of\\:\\ 0\\.00680314165243728\ \(0\)\
\-\ patient\\:\\ 0\\.006252495846105021\ \(0\)\
\-\ in\\:\\ 0\\.006151784381609561\ \(0\)\
\-\ \\(\\:\\ 0\\.005272713330247157\ \(0\)\
\-\ \\)\\:\\ 0\\.005208304321994928\ \(0\)\
\-\ the\\:\\ 0\\.005045594332249116\ \(0\)\
\-\ \\,\\:\\ 0\\.003951971759376458\ \(0\)\
\-\ to\\:\\ 0\\.0031172854630874907\ \(0\)\
\-\ and\\:\\ 0\\.0026278686968207073\ \(0\)\
\-\ with\\:\\ 0\\.0025621352428443008\ \(0\)\
\-\ \\.\\:\\ 0\\.0015547242086429026\ \(0\)\
